Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content + • History of irradiation to the neck (in some patients)• Painless or enlarging nodule, dysphagia or hoarseness• Firm or hard, fixed thyroid nodule; cervical lymphadenopathy• Family history of thyroid cancer• Appears later in life• Invasive, nonencapsulated tumor• Patients often die of local recurrence, pulmonary metastases, or both• Microscopically, has 3 different types:1. Giant cell2. Spindle cell3. Small cell +++ Epidemiology + • Occurs principally in women beyond middle life (peak incidence in the seventh decade of life)• 1% of all thyroid cancers• 50% have clinically positive cervical lymph nodes at presentation• 30% have distant metastases at presentation +++ Symptoms and Signs + • Hard, irregular anterior neck mass• Quickly enlarging mass• May be tender• Dyspnea or stridor• Dysphagia or odynophagia + • These tumors are reliably diagnosed by fine-needle aspiration biopsy + • History and physical exam• Fine-needle aspiration biopsy + • Complete surgical resection is the best chance for cure• Local recurrence after surgical treatment is the rule• Combination therapy with chemotherapy and external beam radiation offers the best palliation, but is rarely curative +++ Surgery +++ Indications + • All tumors should be excised as completely as possible• Tracheostomy below the tumor may be helpful for patients with actual or impending airway compromise +++ Contraindications + • Advanced metastatic disease +++ Medications + • Radioiodine ablation 6 weeks after surgery• Thyroid-stimulating hormone suppression with thyroid hormone (may have little effect since cells are undifferentiated) +++ Treatment Monitoring + • Monthly physical exam for local recurrence +++ Prognosis + • Almost all patients have recurrence and die of the disease• Life expectancy after diagnosis is typically about 6 months• 1-year survival is 5-15% +++ References ++Kebebew E et al: Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005;103:1330. [PubMed: 15739211] +++ Practice Guidelines + • The National Comprehensive Cancer Networkhttp://www.NCCN.org/ Your Access profile is currently affiliated with '[InstitutionA]' and is in the process of switching affiliations to '[InstitutionB]'. Please click ‘Continue’ to continue the affiliation switch, otherwise click ‘Cancel’ to cancel signing in. Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Username Error: Please enter User Name Password Error: Please enter Password Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth